Differential susceptibility of naïve and activated human γδ T cells to activation-induced cell death by T-cell receptor cross-linking

Molecular Medicine

Volumn 7, Issue 9, 2001, Pages 636-643

  Gan, Yunn Hwen ^a   Lui, Shirley S N ^a   Malkovsky, Miroslav ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYTOKINE; FAS ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA; T LYMPHOCYTE RECEPTOR;

ARTICLE; AUTOIMMUNE DISEASE; BLOOD; CELL ACTIVATION; CELL CYCLE; CELL DEATH; CELL ISOLATION; CONTROLLED STUDY; CROSS LINKING; DOWN REGULATION; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INCUBATION TIME; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0035718347     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401870     Document Type: Article

References (35)

1. Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes
2. Homeostasis and self-tolerance in the immune system: Turning lymphocytes off
3. Fas (CD95)/FasL interactions required for programmed cell death after T cell activation
4. Autocrine T-cell suicide mediated by APO- 1/(Fas/CD95)
5. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
6. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis
7. Toso, a cell surface, specific regulator of Fas-induced apoptosis in T cells
8. Inhibition of death receptor signals by cellular FLIP
9. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis
10. Cell cycle progression out of G1 sensitizes primary-cultured nontrans-formed T cells to TCR-mediated apoptosis
11. Differential effects of IL-2 and IL-15 on the death and survival of activated TCRγδ+ intestinal intraepithelial lymphocytes
12. Involvement of the Fas/FasLigand pathway in activation-induced cell death of mycobacteria-reactive human γδ T cells: A mechanism for the loss of γδ T cells in patients with pulmonary tuberculosis
13. Innate T-cell immunity to nonpeptidic antigens
14. Natural T cell immunity to intracellular pathogens and nonpeptidic immunoregulatory drugs
15. Stimulation of γδ T cells by nonpeptidic mycobacterial ligands
16. Natural and synthetic non-peptide antigens recognized by human γδ T cells
17. In vitro stimulation with a non-peptidic alkylphosphate antigen expands cells expressing the Vγ2-Jγ1.2/Vδ2 T cell receptors
18. Human γδ T cells recognize alkylamines derived from microbes, edible plants, and tea: Implications for innate immunity
19. Different roles of the CD2 and LFA-1 T cell co-receptors in regulating cytotoxic, proliferative and cytokine responses of Vγ9/Vδ2 T cells
20. Mechanisms of simian γδ T cell cytotoxicity against tumor and immunodeficiency virus-infected cells
21. Fas-dependent, activation-induced cell death of γδ T cells
22. Role of γδ T lymphocytes in immune response in humans and mice
23. Human T cells require IL-2 but not G1/S transition to acquire susceptibility to Fas-mediated apoptosis
24. Activation-induced cell death in murine T cell hybridomas. Differential regulation of Fas(CD95) versus Fas ligand expression by cyclosporin A and FK506
25. Receptor-stimulated death pathway is opened by antigen in mature T cells
26. TCR engagement regulates differential responsiveness of human memory T cells to Fas (CD95)-mediated apoptosis
27. Differential ability of T cell subsets to undergo activation-induced cell death
28. Regulation of activation-induced cell death of mature T-lymphocyte populations
29. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively
30. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
31. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
32. Peripheral Vγ9/Vδ2 T cell deletion and anergy to nonpeptidic mycobacterial antigens in asymptomatic HIV-1-infected persons
33. Functional γδ T-lymphocyte defect associated with human immunodeficiency virus infections
34. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: γδ T lymphocytes and NK cells
35. In vivo γδ T-cell priming to mycobacterial antigens by primary M. tuberculosis infection and exposure to nonpeptidic ligands